In cell and gene therapy manufacturing, a contamination event during fill-finish doesn’t just cost product; it can cost months of patient wait time. The fluid pa...

Biopharmaceutical manufacturing continues to evolve as upstream titres increase, therapeutic modalities diversifyand continuous processing approaches gain wider ...

In modern scientific environments, the reliability of sample identification underpins the integrity of research,diagnostics and patient care. As laboratories con...

Idiopathic pulmonary Fibrosis (IPF) is described clinically as a chronic and progressive interstitial lung disease.Patients are faced with limited treatment options ...

Forecasting demand and planning capacity is a critical component for all biopharmaceutical companies preparing to launch a new product. To create this forecast, it m...

In biopharmaceutical production, a thorough understanding of analytical processes and target molecules is essential for ensuring patient safety, as well as maint...

Part 3: Pilot and Manufacturing Scale Comparison of DynaDrive S.U.B. Capabilities Introduction Commercialisation of a drug is a monumental milestone that h...

The aProximateTM Proximal Tubule Cell (PTC) model offers a cutting-edge platform for the evaluation of drug-induced nephrotoxicity, radioconjugate retention and ...